Biologics

Merck Wants To Develop Follow-On Biologics

2 Comments

By Ed Silverman // December 9th, 2008 // 10:11 am

FTC Holds Roundtable On Follow-On Biologics

4 Comments

By Ed Silverman // November 21st, 2008 // 7:22 am

Pharmalot… Pharmalittle… Morning Edition

Make a comment

By Ed Silverman // November 19th, 2008 // 6:12 am

Biologics Have High Rate Of Safety Risks: Study

4 Comments

By Ed Silverman // October 21st, 2008 // 10:37 am

Specialty Med Prices Greatly Outstrip Inflation

1 Comment

By Ed Silverman // September 25th, 2008 // 1:07 pm

What Some Employers Think About Drug Prices

4 Comments

By Ed Silverman // September 25th, 2008 // 11:06 am

Obama & McCain Agree On One Thing: Generics

Make a comment

By Ed Silverman // September 18th, 2008 // 1:36 pm

FTC Reviewing Follow-On Biologics And Competition

Make a comment

By Ed Silverman // August 28th, 2008 // 4:38 pm

Those Pricey Drugs Hurt Oncologists, Too

12 Comments

By Ed Silverman // July 8th, 2008 // 7:40 am

Biogenerics Would Save How Much?

2 Comments

By Ed Silverman // June 26th, 2008 // 8:48 am

Older posts »

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/